Research shows that the effectiveness of Bavarian Nordic’s Mpox vaccine drops to undetectable levels after 6-12 months.

A single dose of a smallpox vaccine seems to lower the risk of catching mpox by around 60 per cent, and two doses would ...

Two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine against the deadly infectious disease wanes ...

Social media users claim a vaccine approved for use against mpox could cause a smallpox outbreak, but the only thing ...

Two recent studies reveal that the efficacy of Bavarian Nordic's Mpox vaccine significantly declines within 6-12 months ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox ...

The escalating global Mpox outbreak has been met with a concerning revelation. Two distinct studies have indicated that the ...

Thanks to vaccinations, measles was declared eliminated in the U.S. in 2000. But measles cases are now back; one reason is ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

In August 2024, the World Health Organization (WHO) released an in-depth position paper addressing the use of vaccines ...

A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S's smallpox vaccine, marketed as Imvamune in Canada and ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...